Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Stomatological Hospital of ChongQing Medical University manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action currently active. This action is located within the distinct art units identified in the data, which indicates a specific technical focus for the company's current intellectual property efforts. The concentration in a single art unit suggests that the company is not currently navigating multiple different technical review sections at the USPTO.
The prosecution for this portfolio is conducted by the distinct examiners listed, including MELLER, MICHAEL V. This individual is the busiest examiner for the company, with a busiest examiner pending count of 1. Since the busiest examiner pending count is equal to the total number of pending office actions, the company's entire active prosecution docket is under the review of this one individual. This singular point of contact means that the company's immediate patent outcomes are tied to the specific examination patterns of MELLER, MICHAEL V.
With the specified examiner and art unit involved, the prosecution profile is highly focused. There are no other pending actions identified in the current data. The company's primary objective is to address its current workload within the Biotechnology & Pharmaceuticals sector. This streamlined structure allows for a dedicated response strategy tailored to the requirements of the single examiner involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MELLER, MICHAEL V | 1 | 47.1% | +28.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17433505 | MEDICAL ADHESIVE AND THE PREPARATION METHOD AND USE THEREOF | MELLER, MICHAEL V | 282d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17433505 | MEDICAL ADHESIVE AND THE PREPARATION METHOD AND USE THEREOF | MELLER, MICHAEL V | 282d overdue |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17433505 | MEDICAL ADHESIVE AND THE PREPARATION METHOD AND USE THEREOF | MELLER, MICHAEL V | 1655 | §101§103 | Final Rejection | 282d overdue | Pending | Apr 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial